Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,836
archived clinical trials in
Leukemia

Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Palmetto Health Richland
2319
mi
from 98109
Columbia, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Palmetto Health Richland
2319
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
BI-LO Charities Children's Cancer Center
2224
mi
from 98109
Greenville, SC
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
BI-LO Charities Children's Cancer Center
2224
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center - Sioux Falls
1263
mi
from 98109
Sioux Falls, SD
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
1263
mi
from 98109
Sioux Falls, SD
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
T C Thompson Children's Hospital
2083
mi
from 98109
Chattanooga, TN
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
T C Thompson Children's Hospital
2083
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University/Ingram Cancer Center
1971
mi
from 98109
Nashville, TN
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Sciences Center at Amarillo
1358
mi
from 98109
Amarillo, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center at Amarillo
1358
mi
from 98109
Amarillo, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
1677
mi
from 98109
Dallas, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
1890
mi
from 98109
Houston, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Covenant Children's Hospital
1438
mi
from 98109
Lubbock, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Covenant Children's Hospital
1438
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of San Antonio
1786
mi
from 98109
San Antonio, TX
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of San Antonio
1786
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
2326
mi
from 98109
Burlington, VT
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Naval Medical Center - Portsmouth
2429
mi
from 98109
Portsmouth, VA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Naval Medical Center - Portsmouth
2429
mi
from 98109
Portsmouth, VA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic Children's Hospital
2245
mi
from 98109
Roanoke, VA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic Children's Hospital
2245
mi
from 98109
Roanoke, VA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
2
mi
from 98109
Seattle, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
229
mi
from 98109
Spokane, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
229
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Mary Bridge Children's Hospital and Health Center
26
mi
from 98109
Tacoma, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Mary Bridge Children's Hospital and Health Center
26
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Madigan Army Medical Center
27
mi
from 98109
Tacoma, WA
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Madigan Army Medical Center
27
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
West Virginia University Charleston Division
2129
mi
from 98109
Charleston, WV
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
West Virginia University Charleston Division
2129
mi
from 98109
Charleston, WV
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
1646
mi
from 98109
Green Bay, WI
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
1646
mi
from 98109
Green Bay, WI
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated:  12/31/1969
Monash Medical Center-Clayton Campus
mi
from 98109
Clayton,
Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Status: Enrolling
Updated: 12/31/1969
Monash Medical Center-Clayton Campus
mi
from 98109
Clayton,
Click here to add this to my saved trials
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Phase I/II Study of Hyper-CVAD Plus RAD001 (Everolimus) for Patients With Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Phase I/II Study of Hyper-CVAD Plus RAD001 (Everolimus) for Patients With Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Rockefeller University
2401
mi
from 98109
New York, NY
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Rockefeller University
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
1681
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Boston
2484
mi
from 98109
Boston, MA
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Boston
2484
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital
1966
mi
from 98109
Cincinnati, OH
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Lymphoblastic Leukemia or Lymphoma, or Biphenotypic Leukemia
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Lymphoblastic Leukemia or Lymphoma, or Biphenotypic Leukemia
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Medical Office -Vandever Medical Office
1061
mi
from 98109
San Diego, CA
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Medical Office -Vandever Medical Office
1061
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Tunnell Cancer Center at Beebe Medical Center
2414
mi
from 98109
Lewes, DE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Tunnell Cancer Center at Beebe Medical Center
2414
mi
from 98109
Lewes, DE
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
CCOP - Christiana Care Health Services
2357
mi
from 98109
Newark, DE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
CCOP - Christiana Care Health Services
2357
mi
from 98109
Newark, DE
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Louis A. Weiss Memorial Hospital
1728
mi
from 98109
Chicago, IL
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Louis A. Weiss Memorial Hospital
1728
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Fort Wayne Medical Oncology and Hematology
1871
mi
from 98109
Fort Wayne, IN
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Fort Wayne Medical Oncology and Hematology
1871
mi
from 98109
Fort Wayne, IN
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Holden Comprehensive Cancer Center at University of Iowa
1557
mi
from 98109
Iowa City, IA
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Holden Comprehensive Cancer Center at University of Iowa
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Harold Alfond Center for Cancer Care
2483
mi
from 98109
Augusta, ME
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Harold Alfond Center for Cancer Care
2483
mi
from 98109
Augusta, ME
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
CancerCare of Maine at Eastern Maine Medical Center
2517
mi
from 98109
Bangor, ME
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
CancerCare of Maine at Eastern Maine Medical Center
2517
mi
from 98109
Bangor, ME
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs Medical Center - Minneapolis
1394
mi
from 98109
Minneapolis, MN
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Medical Center - Minneapolis
1394
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Southeast Cancer Center
1800
mi
from 98109
Cape Girardeau, MO
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Southeast Cancer Center
1800
mi
from 98109
Cape Girardeau, MO
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Ellis Fischel Cancer Center at University of Missouri - Columbia
1610
mi
from 98109
Columbia, MO
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Ellis Fischel Cancer Center at University of Missouri - Columbia
1610
mi
from 98109
Columbia, MO
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Goldschmidt Cancer Center
1629
mi
from 98109
Jefferson City, MO
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Goldschmidt Cancer Center
1629
mi
from 98109
Jefferson City, MO
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Missouri Baptist Cancer Center
1710
mi
from 98109
Saint Louis, MO
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Missouri Baptist Cancer Center
1710
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center
1266
mi
from 98109
Grand Island, NE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center
1266
mi
from 98109
Grand Island, NE
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Callahan Cancer Center at Great Plains Regional Medical Center
1155
mi
from 98109
North Platte, NE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Callahan Cancer Center at Great Plains Regional Medical Center
1155
mi
from 98109
North Platte, NE
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
1355
mi
from 98109
Omaha, NE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
1355
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/31/1969
Cancer Institute of New Jersey at Cooper - Voorhees
2384
mi
from 98109
Voorhees, NJ
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Molecular Markers Of Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/31/1969
Cancer Institute of New Jersey at Cooper - Voorhees
2384
mi
from 98109
Voorhees, NJ
Click here to add this to my saved trials